(Press-News.org) Bottom Line: In a retrospective study, the 313-SNP breast cancer polygenic risk score (PRS313) blood test could predict future incidents of breast cancer in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS).
Journal in Which the Study was Published: Cancer Epidemiology, Biomarker & Prevention, a journal of the American Association for Cancer Research (AACR)
Author: Jasmine Timbres, clinical information analyst at King’s College London and the study’s lead author, and Elinor J. Sawyer, PhD, the study’s senior author and professor of clinical oncology at King’s College London in the United Kingdom.
Background: Breast cancer is the most common form of cancer in women and contributes to more than 15% of all new cancer cases in the United States. Abnormal cells in the breast ducts (DCIS) and breast lobules (LCIS) can develop into breast cancer, but scientists cannot currently predict which DCIS and LCIS cases will go on to become breast cancer, said Sawyer. “It is therefore very important that we find ways to predict which women with DCIS and LCIS are most likely to develop invasive breast cancer in the future so they can be given the most appropriate treatment and avoid unnecessary treatment,” she said.
Timbres wanted to test whether PRS313 could be a useful tool in filling this gap in risk assessment and guiding treatment. PRS313 is a test that estimates a patient’s breast cancer risk by quantifying which of 313 breast cancer-associated gene abnormalities called SNPs they have. Because PRS313 has been previously validated as a genetic test that can predict the risk of breast cancer in women with no cancer history, Timbres hypothesized that it could be used as a prediction factor for the risk of breast cancer in patients with DCIS or LCIS.
How the Study was Conducted: To test the predictive power of PRS313 in DCIS and LCIS patients, the researchers analyzed the datasets from the U.K. ICICLE and GLACIER studies. The team assessed the PRS313 scores and follow-up data from 2,169 DCIS cases and 185 LCIS cases. For patients with DCIS, the researchers stratified the PRS313 scores into quartiles and compared them with outcomes. For patients with LCIS, they measured associations between increasing PRS313 scores and outcomes.
Results: The study found that, among patients with DCIS, those with PRS313 scores in the highest quartile were 2.03 times as likely to develop cancer in the breast opposite the original breast (i.e., the contralateral breast) compared with patients in the lowest PRS313 quartile. However, the association between a higher PRS313 and future same-breast (ipsilateral) cancer in patients with DCIS was not significant.
In patients with LCIS, an increasing PRS313 score was associated with an increased risk of ipsilateral breast cancer, being 2.16 times more likely to develop ipsilateral disease per increase in PRS313.
Family cancer history also appeared to play a role. The researchers found that, in patients with a family history of breast cancer, increases in PRS313 were associated with a more than threefold increase in the risk of ipsilateral disease after LCIS, and the risk increased to fourfold if patients who had received mastectomy and radiotherapy for their cancer were excluded.
Author’s Comments: “LCIS is not always surgically removed or treated with hormone therapies, as it is considered lower risk than DCIS. However, these results indicate that those with a family history may benefit from such additional treatments, which could reduce their risk of further cancer,” Timbres said.
“The associations found in this study could be useful in helping women decide their treatment options after a diagnosis of DCIS or LCIS,” she added. “By looking at the full picture, rather than just how cells look under a microscope, we can give women more accurate information about their personal risk of recurrence. This could help them make more informed choices about their treatment options and what’s right for them.”
Sawyer noted, “Although more work still needs to be done to confirm the results of this study in other groups of patients or assess additional genetic changes, the results are very promising and have the potential to influence treatment decisions.”
Study Limitations: The study’s limitations include PRS313’s design as a risk score for invasive disease specifically, and the study therefore may not have tested for important but as-yet-unknown genetic changes associated with in situ breast disease. Another limitation is that the number of women with LCIS in the study’s cohorts was quite small, which may have led to the researchers not detecting statistically significant associations.
Funding & Disclosures: The study was funded by Breast Cancer Now, Cancer Research UK, and the Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London. Timbres and Sawyer report no conflicts of interest.
END
A polygenic risk score may predict future breast cancer in patients with early-stage diagnoses
Patients diagnosed with abnormal breast cells were more likely to receive a later diagnosis of breast cancer if their 313-SNP breast cancer polygenic risk score was high
2025-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Genetic test can predict who could develop invasive breast cancer
2025-10-01
Studying a person’s genetic makeup can predict if they will go on to develop invasive breast cancer after abnormal cells have been found in their breast tissue.
For the first time, researchers at King’s College London have shown the connection between a person’s genetic risk score and their risk of developing the disease after irregular cells have been detected.
The research, published in Cancer Epidemiology, Biomarkers & Prevention and funded by Breast Cancer Now, included over 2,000 women in the UK who had been tested for 313 genetic changes, known as a genetic risk score.
These patients had already been diagnosed with either ductal carcinoma in situ (DCIS) ...
Uncovering the molecular basis of long COVID brain fog
2025-10-01
Even though many years have passed since the start of the COVID-19 pandemic, the effects of infection with SARS-CoV-2 are not completely understood. This is especially true for Long COVID, a chronic condition that can develop after COVID-19 that causes a variety of lasting symptoms. Among the most common and debilitating of these is cognitive impairment, often referred to as “brain fog,” which affects over 80% of people with Long COVID. Given the hundreds of millions of global cases, Long COVID represents a massive public health and socioeconomic challenge, as it severely ...
Poor sleep may accelerate brain ageing
2025-10-01
People who sleep poorly are more likely than others to have brains that appear older than they actually are. This is according to a comprehensive brain imaging study from Karolinska Institutet, published in the journal eBioMedicine. Increased inflammation in the body may partly explain the association.
Poor sleep has been linked to dementia, but it is unclear whether unhealthy sleep habits contribute to the development of dementia or whether they are rather early symptoms of the disease. In a new study, researchers at Karolinska Institutet have investigated the link between sleep characteristics and how old the brain appears in relation ...
The Lancet Infectious Diseases: New study suggests risk of long COVID in children may be twice as high after a second infection
2025-09-30
A new study published in The Lancet Infectious Diseases involving over 460,000 children and adolescents across 40 paediatric hospitals in the USA suggests that children who were infected with COVID-19 for the second time during the Omicron wave had more than double the risk of developing long COVID.
Conducted by researchers under the US National Institutes of Health (NIH)-funded RECOVER Initiative*, this is the largest study to date examining the long-term effects of COVID-19 reinfection in young people. The study analysed electronic ...
Risk of long COVID in kids doubles after second infection
2025-09-30
Children and adolescents were twice as likely to experience long COVID after catching COVID for the second time, compared to their peers with a single previous infection, according to a large study funded by the National Institutes of Health (NIH) and published in Lancet Infectious Diseases. These results run counter to the popular perceptions that COVID in children is "mild" and that reinfections with COVID do not carry the same risk of long COVID that initial infections do.
Among the conditions ...
Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests quality of life benefit with twice - (vs once -) daily radiation
2025-09-30
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab to standard of care concurrent chemoradiation for limited-state small cell lung cancer was reported at the American Society for Radiation Oncology 2024 Annual Meeting. Those results showed that adding atezolizumab did not improve overall survival (OS) for this patient population. At the same time, an exploratory analysis reported longer median OS among patients who received twice-a-day radiation, though RT schedule was ...
NRG Oncology trial analysis shows improvement in survival outcomes for glioblastoma patients receiving proton therapy, trial moves to phase III
2025-09-30
Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) for patients with newly diagnosed glioblastoma (GBM). The recent analysis of the proton cohort revealed improved survival for patients receiving proton therapy at 75 Gy. Because this data met the pre-defined survival improvement threshold, they could be used to design and conduct a definitive phase III randomized ...
In a landmark move, ECMWF is poised to announce a new phase in its data sharing strategy
2025-09-30
As part of its strategy and ongoing commitment to open science, ECMWF (The European Centre for Medium-Range Weather Forecasts) has been opening its extensive data catalogue and making its science more widely open and accessible.
The organisation holds one of the world’s largest meteorological archives, exceeding 1.3 exabytes of data. Starting with historical data and charts, and ECMWF is now moving to make real-time forecast data openly available. By making its data openly available, ECMWF is supporting the UN’s Early Warnings for All initiative and enabling societies ...
Seal’s sensitive whiskers hold key to foiling fish escapes
2025-09-30
Life beneath the waves can be a game of cat and mouse. Seals pursue swimming fish by following the tell-tale wakes and spinning vortices they leave behind, sensing the faint swirls with their sensitive whiskers. But fish might have a trick up their sleeves. Yvonne Krüger from University of Rostock, Germany, explains that escaping fish produce three jets of different sizes they dart away, squirting in individual directions almost simultaneously – at least two of which form into vortex rings, like smoke rings – which could confuse a seal. But might seals be able to see through the ...
Neurological outcomes after patients suffer cardiac arrest at home are similar between low- and high-income areas in Vienna
2025-09-30
Vienna, Austria: People who have a cardiac arrest in their own homes have similar neurological outcomes regardless of socioeconomic background, according to research presented at the European Emergency Medicine Congress today (Wednesday) [1].
However, the study of 676 patients who received treatment in the Department of Emergency Medicine at the Medical University of Vienna suggested that those who lived in lower-income areas may be less likely to receive cardiopulmonary resuscitation (CPR) from bystanders compared to people suffering a cardiac arrest (when the heart stops pumping blood around the body) in higher-income areas – a finding ...
LAST 30 PRESS RELEASES:
Rare fossil reveals ancient leeches weren’t bloodsuckers
Study links shift work to higher risk of kidney stones, influenced by lifestyle factors
Stronger together: Community involvement is key for new transport adoption
Scientific evidence that pianists can change timbre through touch
A polygenic risk score may predict future breast cancer in patients with early-stage diagnoses
Genetic test can predict who could develop invasive breast cancer
Uncovering the molecular basis of long COVID brain fog
Poor sleep may accelerate brain ageing
The Lancet Infectious Diseases: New study suggests risk of long COVID in children may be twice as high after a second infection
Risk of long COVID in kids doubles after second infection
Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests quality of life benefit with twice - (vs once -) daily radiation
NRG Oncology trial analysis shows improvement in survival outcomes for glioblastoma patients receiving proton therapy, trial moves to phase III
In a landmark move, ECMWF is poised to announce a new phase in its data sharing strategy
Seal’s sensitive whiskers hold key to foiling fish escapes
Neurological outcomes after patients suffer cardiac arrest at home are similar between low- and high-income areas in Vienna
Precision without incision: the new era of functional radiosurgery
University of Miami scientists launch accessible global climate modeling framework
Parallel atom-photon entanglement paves way for future quantum networking
Single-step battery cathode recycling
Farm conservation is an economical path to save Colorado River water
Feeling in control helps beat daily stress, researchers find
The Municipal Finance Journal joins the Chicago Journals program
Antarctic icefish rewired their skulls to win an evolutionary arms race
Moffitt study shows promise for new treatment in patients with leptomeningeal disease
CU Anschutz School of Medicine researchers identify new method for treating alcohol use disorder
Stowers Institute recruits renowned developmental and evolutionary biologist from HHMI’s Janelia Research Campus
Can digital health tools help younger cancer survivors better predict future health risks?
Scientists uncover room-temperature route to improved light-harvesting and emission devices
Intergovernmental platform on biodiversity issues an urgent call to stem decline of nature
New AI tool scans social media for hidden health risks
[Press-News.org] A polygenic risk score may predict future breast cancer in patients with early-stage diagnosesPatients diagnosed with abnormal breast cells were more likely to receive a later diagnosis of breast cancer if their 313-SNP breast cancer polygenic risk score was high